Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Phase 3 trials are ongoing, and no regulatory submission has yet been made to the MHRA or EMA
Drivers Impact Analysis Specialist access constraints: Virtual clinics are expected to extend obesity-medicine expertise beyond locations with local specialists
Upgraded protocols & add-ons available
GHK-Cu is a copper-binding tripeptide that signals fibroblasts to increase collagen, elastin, and glycosaminoglycan production while reducing excess collagen breakdown
For standard doses between 2.5 mg and 10 mg, the 1 mL (100 unit) syringe works perfectly
Polypeptide.ltds meticulous research has led to a medication that targets not one, not two, but three hunger-reducing hormones: GIP, GLP-1, and glucagon receptor
